A co-formulation of interferons type I and II enhances temozolomide response in glioblastoma with unmethylated MGMT promoter status

D Vázquez-Blomquist, Sieger Leenstra, Mariëlle van der Kaaij, A Villarreal, I Bello-Rivero

Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Scopus)

Access to Document

@article{c4165ed56d8e472eb9106269136755ec,

title = "A co-formulation of interferons type I and II enhances temozolomide response in glioblastoma with unmethylated MGMT promoter status",

author = "D V{\'a}zquez-Blomquist and Sieger Leenstra and {van der Kaaij}, Mari{\"e}lle and A Villarreal and I Bello-Rivero",

year = "2020",

doi = "10.1007/s11033-020-05604-2",

language = "English",

volume = "47",

pages = "5263--5271",

journal = "Molecular Biology Reports",

issn = "0301-4851",

publisher = "Springer Science+Business Media",

number = "7",

}

TY - JOUR

T1 - A co-formulation of interferons type I and II enhances temozolomide response in glioblastoma with unmethylated MGMT promoter status

AU - Vázquez-Blomquist, D

AU - Leenstra, Sieger

AU - van der Kaaij, Mariëlle

AU - Villarreal, A

AU - Bello-Rivero, I

PY - 2020

Y1 - 2020

U2 - 10.1007/s11033-020-05604-2

DO - 10.1007/s11033-020-05604-2

M3 - Article

C2 - 32607953

SN - 0301-4851

VL - 47

SP - 5263

EP - 5271

JO - Molecular Biology Reports

JF - Molecular Biology Reports

IS - 7

ER -